NCT02145676View on ClinicalTrials.gov

OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity

PHASE3TerminatedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Muscle SpasticityStroke
Interventions
BIOLOGICAL

onabotulinumtoxinA

OnabotulinumtoxinA injected into predefined muscles of the study limb on Day 1.

DRUG

placebo (normal saline)

Placebo (normal saline) injected into predefined muscles of the study limb on Day 1.

Trial Locations (2)

Unknown

Overland Park

Montreal

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY